Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Terpene-enriched CBD oil (various terpene blends)
- Development stage
- Unknown
- Lead developer
- Bazelet Group
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral, Sublingual
01
Overview
Terpene-enriched CBD oil (various terpene blends) is a standardized, non-generic botanical cannabinoid formulation developed by Bazelet Group. It comprises cannabidiol (CBD) and low-dose tetrahydrocannabinol (THC) or is THC-free, enriched with a carefully selected blend of calming and anxiolytic terpenes (such as alpha-pinene, limonene, linalool, beta-caryophyllene, and nerolidol) in optimized ratios. This formulation is designed to leverage synergistic cannabinoid-terpene interactions (the entourage effect) to enhance therapeutic efficacy and reduce the required cannabinoid doses, thereby minimizing potential side effects. It is primarily being developed for the treatment of behavioral and core symptoms of Autism Spectrum Disorder (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD).
- Brand names
- BCANN ASD
- Other names
- BCANN ASD T1/C20Terpene-enriched CBD oilTerpene-enriched CBD oil case-report formulationsTerpene-enriched CBD-dominant oilTerpene-enriched cannabis oil T1/C28
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on Terpene-enriched CBD oil (various terpene blends).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Terpene-enriched CBD oil (various terpene blends).